G1 Therapeutics
Manufacturing · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
700 Park Offices Dr Ste 200, Durham, Nor...Phone Number
(919) 213-9835Website
www.g1therapeutics.comRevenue
$58.2 MillionStock Symbol
GTHXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About G1 Therapeutics
Founded in 2008, G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and delivery of therapies that improve the lives of those affected by cancer. The company's headquartered in Research Triangle Park, North Carolina.Explore more
G1 Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is G1 Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if G1 Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once G1 Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when G1 Therapeutics launches new products
Check if G1 Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if G1 Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on G1 Therapeutics recently announced quarterly report
G1 Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at G1 Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at G1 Therapeutics
Find 2 more new buyers
Compare Similar Companies to G1 Therapeutics
Compare insights from companies similar to G1 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
G1 Therapeutics
$58.2M
51-200
Public
$206.2M
2008
WP
Whitney PageChief of Staff & Director, Corporate Development
Company Profile Activity
Activity Insights
G1 Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
G1 Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about G1 Therapeutics.
G1 Therapeutics financials insights
Gather financial insights about G1 Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Debt
$1.2M
2017
Stock Offering
$105M
2020
Debt
$100M
G1 Therapeutics Tech Stack
A closer look at the technologies used by G1 Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Earnings
Partnership, Business Development, Business Finance, Finance
Earnings
Financial Planning
Earnings
Clinical Operations, Operations
Earnings
G1 Therapeutics News & Media
Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer
Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender OfferPharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period
Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting PeriodPharmacosmos picks up G1 Therapeutics, FDA-approved drug Cosela in merger worth $405M
In a deal worth approximately $405 million, Danish drugmaker Pharmacosmos has agreed to acquire G1 Therapeutics and the latter company's flagship product Cosela. | The companies will team up to expand the reach of G1's Cosela, which is used to reduce bone marrow damage associated with certain chemotherapy regimens.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding G1 Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2008, G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and delivery of therapies that improve the lives of those affected by cancer. The company's headquartered in Research Triangle Park, North Carolina.... Read More
